The QualityStocks Daily Friday, October 26th, 2018

Today's Top 3 StockMarketWatch

MarketClub Analysis (YECO) +66.20%

StockMarketWatch (CREG) +24.96%

StocksToBuyNow (DVLP) +17.92%

The QualityStocks Daily Stock List

Covalon Technologies Ltd. (CVALF)

OTC Markets, TradingView, InvestorsHangout, Proactive Investor, Penny Stock Picks, Penny Stock Tweets, Stockhouse, Barchart, Wallet Investor, 4-Traders, InvestorsHub, CapitalCube, and Stockwatch reported earlier on Covalon Technologies Ltd. (CVALF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Covalon Technologies Ltd. is an advanced medical technologies company headquartered in Mississauga, Ontario. Covalon researches, develops and commercializes new healthcare technologies. The Company’s patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon Technologies lists on the OTC Markets Group’s OTCQX.

The Company has established a Special Committee of the Board of Directors to evaluate potential acquisitions, strategic alliances, and partnerships. This is in response to the interest generated following its earlier announcement of its $100 million contract awards in the Middle East.

Covalon’s technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. The Company’s Advanced Wound Care line has been specially designed for the successful treatment of a wide assortment of wounds.

Concerning Infection Prevention, Covalon Technologies has its highly lubricious and top-quality antimicrobial protection SilverCoat™ Foley catheter. Furthermore, the Company has its dual antimicrobial silicone adhesive platform across the MediClear™ PreOp, SurgiClear™ and IV Clear™ brands.

Covalon’s Perioperative Care brands, MediClear™ and SurgiClear™ offer a range of care throughout a patient’s surgical journey. Covalon has its Technology platforms. These are its Biomatrix Platform, its Antimicrobial Silicone Platform, as well as its Medical Coating Platform.

At the beginning of October, Covalon Technologies announced that it closed the acquisition of AquaGuard, the Seattle, Washington-headquartered division of medical technologies company Cenorin, LLC. AquaGuard's specialized products provide patients with important moisture protection for wound, surgical, and vascular access sites throughout the body while showering.

AquaGuard's family of products provide protection for sites and dressings all over the body. Moreover, they can be applied by most patients without the need of assistance from medical professionals. Covalon Technologies acquired all of the assets and staff dedicated to the AquaGuard business from Cenorin, LLC.

Covalon Technologies Ltd. (CVALF), closed Friday's trading session at $4.72, down 2.55%, on 1,200 volume with 5 trades. The average volume for the last 3 months is 3,640 and the stock's 52-week low/high is $2.59/$7.12.

chart

Arch Biopartners, Inc. (ACHFF)

Stockwolf, Business Insider, Investors Hangout, OTC Markets, Barchart, Wallet Investor, Wall Street Alerts, Stockwatch, Marketwired, TradingView, InvestorPoint, Infront Analytics, 4-Traders, Stockhouse, and MarketWatch reported previously on Arch Biopartners, Inc. (ACHFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Arch Biopartners, Inc. is a portfolio-based biotechnology company headquartered in Toronto, Ontario. It centers on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch Biopartners lists on the OTC Markets’ OTCQB.

The Company has established a diverse portfolio that includes Metablok (LSALT peptide). This is a potential treatment for inflammation, sepsis and cancer metastasis. Additionally, Arch’s portfolio includes AB569. This is a potential new treatment for antibiotic resistant bacterial infections in the lung, urinary tract or wounds.

Arch’s portfolio additionally includes ‘Borg’ peptide coatings. These coatings increase corrosion resistance and reduce bacterial biofilm on different medical grade metals and plastics. The Company’s two lead commercial technologies (MetaMx and ABP569) are on course to enter human clinical trials this year.

Metablok (renamed “LSALT peptide” in Arch Biopartners communications with the Food and Drug Administration [FDA]) is a novel peptide drug candidate in the Arch development pipeline. It is a potential treatment for inflammation, sepsis and cancer metastasis. MetaMx™ consists of novel, synthetic peptide, which target and attach to BTICs and invasive glioma cells, for the purpose of imaging, diagnosis, and developing targeted therapies to improve patient outcomes and survival rates among glioblastoma patients.

In August, Arch Biopartners announced it engaged Dalton Pharma Services to perform the good manufacturing practice (GMP) campaign for Metablok, (LSALT peptide), Arch's drug candidate for preventing acute kidney injury. Dalton Pharma Services will be responsible for the GMP preparation and filling of Metablok into glass vials through to the release of a clinical drug product.

In late September, Arch Biopartners announced that Dalton Pharma Services completed the good manufacturing practice (GMP) glass vial filling stage for Metablok. Over the next six to eight weeks Dalton will be completing the quality control process that will conclude with the release of a clinical drug product to be used in a Phase I safety trial for Metablok. Arch Biopartners is waiting for the completion of continuing toxicology and pharmacology studies at Nucro-Technics in November before confirming the commencement date of the Phase I human trial.

Arch Biopartners, Inc. (ACHFF), closed Friday's trading session at $1.0557, down 5.39%, on 2,800 volume with 1 trade. The average volume for the last 3 months is 2,794 and the stock's 52-week low/high is $0.316/$1.37.

chart

BioElectronics Corporation (BIEL)

StreetInsider, Barchart, and InvestorsHub reported on BioElectronics Corporation (BIEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioElectronics Corporation is a leader in non-invasive electroceuticals. The Company is the maker of an industry leading family of disposable, drug-free, pain therapy devices. BioElectronics’ unique medical devices safely and effectively treat chronic and acute pain through an innovative mechanism of non-invasive sub-sensory neuromodulation. BioElectronics is based in Frederick, Maryland and the Company lists on the OTC Markets.

BioElectronics’ products include RecoveryRx® and ActiPatch. RecoveryRx® uses pulsed electromagnetic therapy to lessen pain and inflammation resulting in accelerated patient recovery and improved comfort. For medical professionals, the RecoveryRx® medical device provides a safe and cost-effective pain management therapy.

ActiPatch® provides advanced long-lasting chronic pain relief using Electromagnetic Pulse Therapy. It is a new and clinically proven drug free technology in the battle against chronic pain.

Bioelectronics’ products also include Smart Insole™, Allay® Menstrual Pain Relief, and HealFast® Veterinary Pain Relief. The Smart Insole™ consists of Electro-Pulse micro medical devices. These are embedded in comfortable heel gel inserts. HealFast® Therapy is a drug-free therapy for horses, cats and dogs. It reduces swelling and pain while it speeds up healing of muscle and tendon injuries, sores, and incisions. Allay® is an award-winning drug-free micro medical device. It utilizes Electromagnetic Pulse Therapy to lessen menstrual pain and discomfort.

BioElectronics announced in May 2018 that B. Braun Ltd, of Sheffield, United Kingdom (UK) completed development of its same day surgical TOTAL Pathway program for joint replacements, which includes BioElectronics’ medical devices. The program is being launched by B. Braun’s UK Group to improve care and reduce the UK healthcare cost of its 160,000 yearly hip and knee replacement procedures.

This month, BioElectronics announced the publication of an article in the October 2018 edition of the European Biopharmaceutical Review. Titled “Effective Electroceuticals,” this article provides insights into how electroceuticals (devices that provide electrical therapy) are set to transform chronic pain management in the 21st century. The article was authored by Dr. Kenneth McLeod, Ph.D., Director of the Clinical Science and Engineering Research Laboratory at the State University of New York, Binghamton and Dr. Sree Koneru, Ph.D., VP of Product Development at BioElectronics.

BioElectronics Corporation (BIEL), closed Friday's trading session at $0.0024, up 4.35%, on 18,857,060 volume with 42 trades. The average volume for the last 3 months is 26,953,796 and the stock's 52-week low/high is $0.0005/$0.005.

chart

Bimini Capital Management, Inc. (BMNM)

Zacks, Stockopedia, Information Vine, OTC Markets, InvestorsHub, MarketWatch, and Stockhouse reported on Bimini Capital Management, Inc. (BMNM), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

A specialty finance company, Bimini Capital Management, Inc. primarily invests in mortgage-backed securities (MBS) in the United States. The Company is an asset manager. It invests mainly in residential mortgage-related securities issued by the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac), and the Government National Mortgage Association (Ginnie Mae).

Established in 2003, Bimini Capital Management has its corporate office in Vero Beach, Florida. The Company previously went by the name Opteum, Inc. It changed its name to Bimini Capital Management, Inc. in September of 2007. The Company lists on the OTC Markets Group’s OTCQB.

Bimini Capital Management’s goal is to earn returns on the spread between the yield on its assets and its costs. This includes the interest expense on the funds it borrows.

In addition, the Company generates a substantial portion of its revenue serving as the manager of the MBS portfolio of Orchid Island Capital, Inc.  Orchid Island Capital is a publicly-traded real estate investment trust (REIT) (NYSE: ORC).

Bimini Capital Management, as manager, is responsible for administering Orchid Island Capital’s business activities and day-to-day operations.  With this management agreement, Bimini Advisors provides Orchid with its management team, including its officers, along with suitable support personnel. Furthermore, Bimini maintains a common stock investment in Orchid.

Bimini also manages the portfolio of its wholly-owned subsidiary, Royal Palm Capital, LLC. Royal Palm Capital is managed with an investment strategy similar to that of Orchid Island Capital.

Yesterday, Bimini Capital Management announced results of operations for the three month period ended March 31, 2018. It reported a Net Loss of $3.3 million for the three month period ended March 31, 2018.

The results included advisory services revenue of $2.1 million, interest and dividend income of $2.6 million, interest expense of $1.1 million, net realized and unrealized losses of $6.1 million, operating expenses of $1.7 million, as well as an income tax benefit of $1.1 million.

Bimini Capital Management, Inc. (BMNM), closed Friday's trading session at $2.18, up 0.46%, on 285 volume with 3 trades. The average volume for the last 3 months is 3,798 and the stock's 52-week low/high is $1.86/$2.75.

chart

Lot78, Inc. (LOTE)

Promotion Stock Secrets, Street Register, OTC Markets, Emerging Growth, Aim High Profits, Insider Financial, Penny Stock Tweets, Stockwatch, Penny Stock Dream, Hotstocked, and Predict Wall Street reported on Lot78, Inc. (LOTE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Lot78, Inc. designs, markets, distributes and sells apparel under the Lot78 brand name. It operates in three segments: Wholesale, Consumer Direct, and Core Services. Ollie Amhurst is the Founder and Creative Director of the Company. From the start, the business strategy was to build Lot78 into a men’s and women’s ready to wear line. Lot78 has its head office in London, England.

The Company was incorporated in Nevada on June 27, 2008. On March 14, 2011, it filed a Certificate of Amendment with the Secretary of State of Nevada changing the name of the Company to "Bold Energy, Inc."

On November 12, 2012, the Company, then under the name Bold Energy, entered into a Share Exchange Agreement with Anio Limited a limited liability company formed under the laws of the United Kingdom (Anio Ltd.) that conducts its main line of business under the name Lot78, Inc., the shareholders of Anio Ltd., and the controlling stockholders of the Company.

On January 31, 2013, it changed names to Lot78, Inc.  On July 15, 2016, the Company entered into a Letter of Intent (LOI) to merge with Compound Holdings, LLC, a Connecticut limited liability company. Then, on July 18, 2016, the Company and Compound Holdings LLC entered into a definitive Agreement and Plan of Merger. With this plan of merger, upon closing, its intention is to change its name to Compound Holdings, Inc.

Lot78 offers a collection of men's and women's ready to wear line that includes leather jackets, T-shirts, sweats, knitwear, accessories, jeans, chinos, and wool coats. The Company sells its products to department stores, specialty retailers, and boutiques. In addition, it sells its products via lot78.com.

In October of 2017, Lot78 announced that it was scheduled to acquire a 2.5 percent equity stake in Garage Juice Bar, LLC also known as Juice Bar Electric Vehicle Charging Stations. Lot78 stated that this investment aligns with the Company’s mission to provide value to shareholders via the acquisition of investments, which show potential to be scaled regionally and/or nationally or investments that drive outsized returns.

Lot78, Inc. (LOTE), closed Friday's trading session at $0.0214, up 5.42%, on 3,300 volume with 2 trades. The average volume for the last 3 months is 47,921 and the stock's 52-week low/high is $0.012/$0.075.

chart

Black Cactus Global, Inc. (BLGI)

Stockopedia, Dividend Investor, PennyStockHub, StreetInsider, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, InvestorsHub, OTC Markets, Insider Financial, 4-Traders, Morningstar, Stockhouse, Simply Wall St, MarketNewsUpdates.com, TipRanks, InvestorsHangout, and The Street reported on Black Cactus Global, Inc. (BLGI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Black Cactus Global, Inc. is a technology development company based in Las Vegas, Nevada. The Company focuses on Blockchain, machine learning, cryptocurrency, and the Internet of Things (IoT). Its mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. Black Cactus Global lists on the OTC Markets’ OTCQB.

Black Cactus Global’s strategic plan is to become the first completely integrated digital financial institution with Blockchain technology as its operating foundation. The Company specializes in worldwide development and consulting projects in its key development areas of FinTech, digital media, financial services, KYC, AML, cyber security, and healthcare.

Black Cactus Global is developing Blockchain applications for Fintech, Healthcare, Media and Supply Chain utilizing smart contracts and machine learning.

The Company’s services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems. In addition, its services include Crypto Currencies, Internet of Things (IoT), Smart Contracts, and Fintech & Medtech.

Black Cactus Global announced this past January that it entered into an MOU with the majority shareholders in an Indian Technology firm to form a subsidiary of the Company. With this MOU, Black Cactus will become the largest stakeholder of an international Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will center on and advance the use of its unique Blockchain based IP.

Last week, Black Cactus Global announced that it completed a share exchange agreement with the Blockchain development subsidiary, Black Cactus Global Technologies Pvt. Limited (BCG-TPL). This agreement calls for Black Cactus Global to own an initial 29 percent interest in BCG-TPL, which has already attained major milestones that will enable the Company to scale-up development activities. The modern facility will house one of the larger Blockchain development teams.

Today, Black Cactus Global announced that it has withdrawn its participation in a plan to acquire a bank in Iceland with NSB Holdings ehf, for the purpose of creating the first completely digital bank. It concluded, after a strategic review, that the plan would involve many competitive risks, which would impact the economic feasibility of such a project. It also concluded that it would divert Black Cactus Global’s focus away from its main activity, which is the development of Blockchain applications for the efficient management of financial and administrative processes across numerous industries.

Black Cactus Global, Inc. (BLGI), closed Friday's trading session at $0.038, up 1.33%, on 24,475 volume with 12 trades. The average volume for the last 3 months is 176,774 and the stock's 52-week low/high is $0.03/$0.69.

chart

Green Cures & Botanical Distribution, Inc. (GRCU)

Penny Stock Tweets, StockGoodies, Capital Cube, Zacks, Front Page Stocks, Simply Wall St, MarketWatch, Stockhouse, InvestorsHub, OTC Markets, Business Insider, ClayTrader, Stockopedia, Barchart, GuruFocus, Marketwired, Investors Hangout, and Daily Marijuana Observer reported on Green Cures & Botanical Distribution, Inc. (GRCU), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Green Cures & Botanical Distribution, Inc. (GRCU) is a hemp-infused nutrition, botanical, sports, and body care products company. It operates a varied portfolio of products and services within the botanical and cannabis industry, as permitted by law. GRCU is continually creating and introducing products that promote a healthy life style. The Company has its corporate headquarters in Inglewood, California.

At present, GRCU is Web-based. Its focus is on online retailing. The Company’s products are branded under the Original Hollywood Hemp™ brand. In addition, it develops beverages branded under the Iconic Beverages ™ name.

Original Hollywood Hemp™ is hemp activated health, beauty, skin care, hair care, spices, fashion, food products and beverages with the active ingredients of hemp. Iconic Beverages™ consists of hemp infused and no hemp infused beverages. Iconic Beverages™ will feature iconic celebrities with exclusive licenses owned by GRCU and its shareholders.

This past February, GRCU announced that it signed a four-year agreement with Humboldt Cannabis AF in California to produce licensed cannabis and CBD products. Humboldt Cannabis AF is a cannabis and CBD company in Humboldt, California.

GRCU will look to products to be sold at retail/dispensary. However, the Company will rely on Humboldt Cannabis AF for CBD product development. Humboldt has a record of accomplishment producing top of the line, exclusively pristine product.

GRCU Chief Executive Officer, Mr. William Pitsicalis, said in February, “The Humboldt AF company is tremendously successful, and we have really enjoyed their work. Green Cures is excited to partner with the company to produce cannabis-infused bath balls, lotions, and other skin and body-care products.”

In April, GRCU announced the expansion of its corporate offices into a new space located in Woodland Hills California. Moreover, the Company has received approval from California for GRCU's newest manufacturing plant.  The plant had been approved for recreational manufactory and sales in the State of California.

Furthermore, vibrant packaging design for the new GRCU product lines has been finalized. GRCU products are being packaged in their new, striking, provocative, Must Have Packages.

Green Cures & Botanical Distribution, Inc. (GRCU), closed Friday's trading session at $0.0051, up 4.08%, on 3,231,530 volume with 36 trades. The average volume for the last 3 months is 2,361,233 and the stock's 52-week low/high is $0.004/$0.056.

chart

Texas Mineral Resources Corp. (TMRC)

Stockrow, OTC Markets, InvestorsHub, and Marketwired reported on Texas Mineral Resources Corp. (TMRC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 1970, Texas Mineral Resources Corp. is an exploration company. It is targeting the heavy rare earths and a variety of other high-value elements and industrial minerals. The Company’s focus is exploring and, if warranted, developing its Round Top heavy rare earth and industrial minerals project in Hudspeth County, Texas, 85 miles east of El Paso, Texas.

OTCQB-listed, Texas Mineral Resources is based in Sierra Blanca, Texas. The Company formerly went by the name Texas Rare Earth Resources Corp. It changed its corporate name to Texas Mineral Resources Corp. in March of 2016.

Last year, The Company added a new strategic line of business with the creation of a subsidiary called American Mineral Reclamation LLC. The creation of this subsidiary is in response to the growing number of opportunities that the Company was presented due to work undertaken with partners that resulted in winning grants from the Department of Defense (Defense Logistics Agency) and the Department of Energy.

Additionally, Texas Mineral Resources’ plan is to develop alternative sources of strategic minerals through the processing of coal waste and other related materials. The Company’s flagship property, Round Top Mountain, is near Sierra Blanca in Hudspeth County.

Round Top is one of four principal rhyolite bodies, an igneous volcanic rock, making up the group of mountains called The Sierra Blanca. The Preliminary Economic Assessment (PEA) has been completed based on the measured, indicated and inferred Resource Estimate Technical Report filed on December 20, 2013 by Texas Rare Earth Resources.

The PEA and resource estimate was prepared by Gustavson Associates of Lakewood, Colorado. The resource incorporated into the current mine plan totals 525.4 million kg of rare earth oxide (REO), with an average grade of 634 ppm total rare earth oxides (TREO). Of the TREO, about 72 percent consist of heavy rare earth oxides plus Yttrium.

Texas Mineral Resources holds 19-year renewable leases from the State of Texas on 950 acres covering Round Top and additional prospecting permits on adjacent areas covering an additional 9,345 acres. Currently, the Company is focusing on the exploration and development of rare earth elements at Round Top.

In December 2017, Texas Mineral Resources announced it strongly supports President Trump’s Executive Order signed on December 20, 2017 titled: “A Federal Strategy to Ensure Secure and Reliable Supplies of Critical Materials”.

A copy of this Executive Order can be found at:  on.doi.gov/2Dp0cBE.

Mr. Anthony Marchese, Chairman of Texas Mineral Resources, said in December, “The USGS list of critical minerals highlights the strategic nature of our projects. Coupled with the President’s Executive Order, we can now see an ‘action plan’ to encourage U.S. production of critical minerals taking shape.”

Texas Mineral Resources Corp. (TMRC), closed Friday's trading session at $0.21, up 2.94%, on 31,855 volume with 8 trades. The average volume for the last 3 months is 27,803 and the stock's 52-week low/high is $0.101/$0.35.

chart

Intrusion, Inc. (INTZ)

Zacks, CapitalCube, Marketbeat, Morningstar, InvestorsHub, 4-Traders, Barchart, The Street, OTC Markets, and MarketWatch reported on Intrusion, Inc. (INTZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Intrusion, Inc. is a global provider of entity identification, high speed data mining, cybercrime, and advanced persistent threat detection products. The Company’s product families include TraceCop™ for identity discovery and disclosure, and Savant™ for network data mining and advanced persistent threat detection. OTCQB-listed, Intrusion is based in Richardson, Texas.

The Company launched its first intrusion detection system (IDS) to the enterprise market in 2000. It was followed in 2002 by the launch of its intrusion prevention system (IPS).

Intrusion’s products help protect critical information assets. These products do so through quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private, and regulated information for government and enterprise networks.

Intrusion’s TraceCop is a set of Internet monitoring and tracking products. They provide unprecedented capabilities for the identification of malicious and illegal activities founded on historical and current Internet usage data. TraceCop helps analysts and investigators substantially reduce the time and complexity for discovering identities, ownership, and contact information for computer devices on the Internet.

At the heart of TraceCop is a premier data collection process. This process continuously collects, processes, as well as stores extensive amounts of historical Internet usage and traffic data into the TraceCop Databases.

The Company’s Savant is a transparent network data capture and analysis solution. Savant brings science into corporate decision making. It provides real-time access and insight into an enterprise’s own indisputable and quantifiable network data for more effective, unbiased decision making.

Savant is a purpose-built appliance. It performs an innovative, real-time, transparent data capture and analysis of all content across a company’s network. This includes the “who, what, when and where” of the data from any application.

Intrusion also has its Secure Taps™. It offers a collection of secure network taps. These enable easy, quick, and strong deployment of any of the Company’s network security appliances. Using a Secure Tap is a first-rate method for deploying network appliances.

This month, Intrusion announced financial results for the quarter ended March 31, 2018. The Company’s Net Income was $346,000 in Q1 2018, versus a Net Loss of $351,000 for Q1 2017 and Net Income of $194,000 for Q4 2017.

Revenue for Q1 2018 was $2.3 million, versus $1.6 million for Q1 2017 and $2.1 million for Q4 2017. Gross Profit Margin was 62 percent of Revenue in Q1 2018; versus 63 percent for Q1 2017 and 58 percent for Q4 2017.

Intrusion, Inc. (INTZ), closed Friday's trading session at $2.60, up 1.23%, on 7,100 volume with 38 trades. The average volume for the last 3 months is 3,066 and the stock's 52-week low/high is $0.26/$2.60.

chart

Solbright Group, Inc. (SBRT)

NetworkNewsWire, Street Insider, OTC Markets, YCharts, Marketbeat, Stockhouse, Barchart, MarketWatch, 4-Traders, TradingView, Penny Stock Hub, OTC Dynamics, InvestorsHub, Wallmine, Business Insider, Morningstar, CapitalCube, Simply Wall St, GuruFocus, WalletInvestor, WhaleWisdom, and Amigo Bulls reported on Solbright Group, Inc. (SBRT), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Solbright Group, Inc. is an industrial automation and energy management company. It provides Industrial Internet of Things (IIoT) solutions that help commercial and industrial facilities increase efficiency and reduce cost. The Company’s focus is towards the development and commercialization of an Internet of Things (IoT) software platform that supports Big Data applications, which complement its energy management services.

Solbright Group is based in Newark, New Jersey. The Company formerly went by the name Arkados Group, Inc. It changed its corporate name to Solbright Group, Inc. in November 2017. The Company lists on the OTCQB.

Solbright has pioneered smart energy solutions and IoT technologies since 2013. The Company’s vision is to help facility operators throughout the United States. improve the operational performance of their facilities through its technology, renewable energy, and energy conservation solutions. Solbright delivers technology solutions for building and machine automation and energy conservation, which complement its energy conservation services such as LED lighting retrofits, HVAC system retrofits and solar engineering, procurement and construction services.

Pertaining its platform, BrightAI is a converged IoT platform. It monitors any IAQ sensor, mechanical sensor, meter, or BACnet device in a facility. BrightAI features energy management and predictive maintenance applications by way of a cloud control dashboard.

Solbright Group announced in January 2018 a new agreement with Ying Wu College of Computing at New Jersey Institute of Technology (NJIT) to advance research and development (R&D) of its industrial internet of things (IIoT) software platform with a focus on leveraging blockchain technology for enhanced security and energy savings monetization.

The design of the partnership is to take advantage of the prestigious advanced research capability of the Ying Wu College of Computing (YWCC) at NJIT to jointly research functional security applications for Solbright Group's advanced IoT platform built for commercial and industrial real estate markets using blockchain technology.

Last month, Solbright Group and M2M Spectrum Networks, LLC announced the completion of their merger to create Iota Communications, Inc. (Iota). This merger brings together two companies at the vanguard of the proliferation of the IoT to form a new company that is the first publicly-traded, pure-play, fully-featured IoT network operating company in the United States.

M2M is the fast-growing, national, dedicated IoT network access and IoT solutions company. With this merger complete, Iota will receive significant funding capability from M2M over the next 18 months. Iota will seek to change its stock trading symbol to reflect the new name while applying for an up-listing of its shares to a major exchange.

Solbright Group, Inc. (SBRT), closed Friday's trading session at $0.725, up 12.06%, on 71,614 volume with 38 trades. The average volume for the last 3 months is 183,558 and the stock's 52-week low/high is $0.275/$1.55.

chart

BAB, Inc. (BABB)

Zacks, Marketbeat, Greenbackers, SmallCapVoice, and OTC Markets Group reported earlier on BAB, Inc. (BABB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BAB, Inc. franchises and licenses Big Apple Bagels®, My Favorite Muffin®, SweetDuet® frozen yogurt, and Brewsters’® Coffee. In addition, BAB engages in the sale of bagels, muffins, and coffee via nontraditional channels of distribution, including under licensing agreements. BAB Systems, Inc. is the Company’s franchising subsidiary. BAB is based in Deerfield, Illinois. The Company’s shares trade on the OTC Markets’ OTCQB.

BAB’s SweetDuet® is a Duet Yourself® frozen yogurt bar. It includes a wide-ranging offering of gourmet muffins. BAB’s Big Apple Bagels is a national chain of fast-casual restaurants. The Company’s My Favorite Muffin is a national chain of fast-casual restaurants with hand-crafted products.

BAB’s Brewsters' Coffee® hand picks only the top 2-3 percent of Arabica beans from around the world. Brewsters’ hand roasts its beans in small batches. Moreover, BAB’s has Jacobs Bros. Bagels (frozen raw dough and par-baked varieties).

BAB garners its revenues primarily from the continuing royalties paid to it by its franchisees and also the receipt of initial franchise fees. Furthermore, the Company receives revenue from the sale of licensed products (My Favorite Muffin mix, Big Apple Bagels cream cheese, Big Apple Bagels frozen bagels, and Brewster's coffee). Royalty fees represent a 5 percent fee on net retail and wholesale sales of franchised units.

The Company earns a licensing fee from the sale of BAB branded products from a third-party commercial bakery, to the franchised and licensed units. BAB’s nontraditional channels of distribution are Kohr Bros. and Green Beans Coffee. Also included in licensing fees and other income is Operation's Sign Shop revenue. The Sign Shop provides most of the signage. This includes but is not limited to, posters, menu panels, outside window stickers, and counter signs to franchisees to provide consistency and convenience.

This past August, BAB Systems, Inc., the wholly-owned subsidiary of BAB, Inc., and Mont Royal Restaurant and Café, LLC, announced that the second of two locations opened under their exclusive licensing agreement for the development of Big Apple Bagels Café’s within the United Arab Emirates (UAE). In addition to bagels, muffins and coffee beverages, the Cafés offer a full service dining experience and a more extensive menu than the typical Big Apple Bagels. The first location opened in January 2018 in Al Ghurair Centre, an upscale mall featuring shopping, dining and entertainment. 

BAB, Inc. (BABB), closed Friday's trading session at $0.70, even for the day. The average volume for the last 3 months is 9,572 and the stock's 52-week low/high is $0.61/$0.74.

chart

Northwest Biotherapeutics, Inc. (NWBO)

PureActionStocks, Pennybuster, The Street, FeedBlitz, AllPennyStocks, BullRally, Marketbeat.com, InvestorPlace, Promotion Stock Secrets, RedChip, Wall Street Corner, BUYINS.NET, WealthMakers, Wealthpire, CoolPennyStocks, StreetInsider, StockPicksNYC, INO.com Market Report, Streetwise Reports, OTCPicks, and SmallCapVoice reported previously on Northwest Biotherapeutics, Inc. (NWBO), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Northwest Biotherapeutics, Inc. is a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers. In the U.S. and Europe, its emphasis is on developing personalized immunotherapy products, on a cost-effective basis, designed to treat cancers more effectively than existing treatments. This is without toxicities of the type associated with chemotherapies. OTCQB-listed, Northwest Biotherapeutics is based in Bethesda, Maryland.

Northwest Biotherapeutics has an extensive platform technology for DCVax dendritic cell-based vaccines. It is working to move ahead with numerous clinical programs, involving DCVax-L and DCVax-Direct.

The Company’s lead program is a 331-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). This trial has completed its enrolment. Northwest Biotherapeutics’ is pursuing completion of the current Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer and pursuing Phase II combination trials of DCVax-L and checkpoint inhibitor drugs. This includes the Phase II trial of DCVax-L and Pembrolizumab (Keytruda) for colon cancer that was previously announced.

The Company earlier received clearance from the Food and Drug Administration (FDA) for a 612-patient Phase III trial in prostate cancer. It received approval in Germany of a five-year Hospital Exemption for the treatment of all gliomas (primary brain cancers) outside the clinical trial.

Northwest Biotherapeutics is also pursuing a Phase I/II trial with DCVax-Direct for all kinds of inoperable solid tumor cancers. It has completed the 40-patient Phase I portion of the trial. It is preparing the Phase II portion. It earlier conducted a Phase I/II trial with DCVax-L for metastatic ovarian cancer in association with the University of Pennsylvania.

Additionally, Northwest Biotherapeutics’ product candidates include DCVax-Prostate. The design of this product is purposely for late stage, hormone independent prostate cancer. The Company has developed a DCVax product line using a particular proprietary antigen — PSMA (Prostate Specific Membrane Antigen). It is found on essentially all late stage (hormone independent) prostate cancer.

The PSMA is produced by way of recombinant manufacturing methods. It is then combined with the fresh, personalized dendritic cells to make DCVax-Prostate.

Recently, Northwest Biotherapeutics announced that its Chief Executive Officer, Ms. Linda Powers, increased her funding to the Company by $1 million, reaching a total of $5.4 million this year to date. On April 26, 2018, Northwest Biotherapeutics and Ms. Powers entered into a note and loan agreement for an additional loan of $1.0 million by Ms. Powers to the Company on the same terms as her previous funding, as earlier reported in March.

Northwest Biotherapeutics, Inc. (NWBO), closed Friday's trading session at $0.195, down 0.51%, on 821,213 volume with 101 trades. The average volume for the last 3 months is 1,037,049 and the stock's 52-week low/high is $0.155/$0.398.

chart

Astea International, Inc. (ATEA)

Stocktwits, OTC Markets, MarketWatch, Zacks, InvestorsHub, Stockhouse, Business Insider, and The Street reported on Astea International, Inc. (ATEA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Astea International, Inc. is a global leader in field service and mobile workforce management. The Company’s solutions unify processes, people, parts, and information to focus the entire organization on the creation of sustainable value in highly competitive, international markets. Astea provides integrated solutions to assist in maximizing efficiencies, improve revenues, as well as enhance customer satisfaction. OTCQB-listed, Astea International is headquartered in Horsham, Pennsylvania.

The Company is a worldwide provider of end-to-end service management software solutions. These solutions offer all the foundations of service lifecycle management. These include customer management, depot repair, service management, asset management, warranty management, forward and reverse logistics, and mobile and optimization.

Astea International has expertise in service management, distribution, logistics, and system applications. The chief elements of its professional services are impact assessment, consulting services, and training & support. The Company provides on-premise and cloud delivery models. This allows every company to select the right one that aligns with their strategy and Information Technology (IT) ecosystem.

Astea, via its Japanese subsidiary, has partnered with Kobelco Systems Corporation. This is to enable wide-ranging Internet of Things (IoT) and Artificial Intelligence (AI) capabilities on its field service management platform, Astea Alliance™. Kobelco Systems' IoT infrastructure platform and AI analytical service are now completely integrated into the Astea Alliance platform to optimize the maintenance activities of original equipment manufacturers (OEMs), improving overall productivity for assembly lines, plants, and supply chains.

Astea International and XOi Technologies have a partnership to expand their combined offerings to field service providers around the world through integrating XOi's Vision™ into the Astea Alliance™ field service management and mobility platform. Vision™ is an augmented reality and visual intelligence solution.

In September, Astea International announced the launch of Alliance Enterprise™. This is the newest version of its award-winning Alliance field service management and mobility platform. Alliance Enterprise introduces to the field service industry a completely new perspective on how an enterprise-grade technology can unify the increasingly complex ecosystem in which service-driven companies must operate.

Alliance Enterprise puts strong capabilities into the hands of non-technical users through a new process flow engine, which offers graphical, drag-and-drop functionality to modify application workflows. The new tool can be used to build flexible, agile business processes that address a broad array of needs such as integrations, multi-channel communication automation and service escalations.

Astea International, Inc. (ATEA), closed Friday's trading session at $6.20, up 3.51%, on 2,945 volume with 14 trades. The average volume for the last 3 months is 2,306 and the stock's 52-week low/high is $2.00/$7.05.

chart

Geospatial Corp. (GSPH)

Penny Sleuth, HotStockChat, SmallCapVoice, and The Street reported on Geospatial Corp. (GSPH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Geospatial Corp. is a foremost innovator of asset management/analytics/mapping software and 3D mapping technologies. It utilizes integrated technologies to ascertain the accurate location and position of underground pipelines, conduits, and other underground infrastructure data. This permits the Company to create accurate three-dimensional (3D) digital maps and models of underground infrastructure. OTCQB-listed, Geospatial has its corporate office in Sarver, Pennsylvania.

The Company provides integrated data acquisition technologies. These technologies accurately locate and map underground and aboveground infrastructure assets, including pipelines and surface features, through Geospatial’s GeoUnderground Cloud-Based Portal. The design of GeoUnderground is around the Google Maps API.

GeoUnderground is the Company’s cloud-based Geographic Information System (GIS) platform. It provides clients with a complete solution to their underground and aboveground asset management requirements. Geospatial uses a collection of data acquisition tools. The Company cost-effectively maps most pipelines to an accuracy of less than 10 cm (3.9 inches).

GeoUnderground is a robust Cloud-Based GIS database. This database allows users to view and use this 3D pipeline mapping information securely from any desktop or mobile device.

Geospatial has new Quality Assurance (QA) and Installed Locational Integrity Management (ILIM) programs for underground pipelines. The Company provides complete QA programs and ILIM programs for underground pipelines and conduits installed through Horizontal Directional Drilling (HDD) methods irrespective of depth, material, or soil conditions. The service addresses the need for accurate 3D mapping of critical pipeline segments that exceeds regulatory requirements and supports integrity and reliability demands.

Geospatial is integrating Blockchain technology with GeoUnderground. This will provide a cloud-based locational software platform allowing energy companies a secure way to manage contracts, assure provenance, and track asset maintenance.

This past July, Geospatial announced that it completed the mapping of six electrical conduits for Crosslinx Transit Solutions - Constructors, (CTS). CTS is a design and construction consortium building the Eglinton Crosstown LRT in Toronto, Ontario. The consortium consists of four international and local leaders in transportation infrastructure: ACS-Dragados, Aecon, EllisDon and SNC-Lavalin. The Eglinton Crosstown Light Rail Transit System comprises 25 stations and stops, tracks, signals, a communications system, and maintenance and storage facilities. Following the Crosstown's completion; CTS will maintain the line for 30 years.

Geospatial Corp. (GSPH), closed Friday's trading session at $0.025, even for the day, on 196,000 volume with 1 trade. The average volume for the last 3 months is 46,989 and the stock's 52-week low/high is $0.0141/$0.048.

chart

The QualityStocks Company Corner

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Changing Attitudes in Washington Offer Promise for Hemp and Cannabis Market,” featuring Marijuana Company of America, Inc. (OTC: MCOA). To hear the CannabisNewsAudio version, visit: http://cnw.fm/2Abq0. To read the full editorial, visit: http://cnw.fm/2Fhng.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0217, up 4.83%, on 6,025,274 volume with 297 trades. The average volume for the last 3 months is 8,891,803 and the stock's 52-week low/high is $0.02/$0.073.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSX.V: RIV) was mentioned today in an article examining how the Bureau of Cannabis Control, together with the Department of Public Health and the Department of Food and Agriculture in California have released an updated draft set of rules that will form the permanent regulations which will govern the cannabis industry in the state.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.50, up 0.22%, on 248,287 volume with 473 trades. The average volume for the last 3 months is 460,659 and the stock's 52-week low/high is $3.18/$11.82.

Recent News

chart

CytoDyn Inc. (CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) has unveiled a comprehensive strategy for the development of a genetic prostate cancer prognostic test (http://nnw.fm/T2RyY). Developed by ProstaGene, an entity that CytoDyn is in the process of acquiring, PCaTest has already demonstrated superior predictive ability in comparison to other genetic prostate cancer tests.

CytoDyn Inc. (CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.5275, up 1.44%, on 142,421 volume with 42 trades. The average volume for the last 3 months is 246,224 and the stock's 52-week low/high is $0.40/$0.836.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Sugarmade, Inc. (OTCQB: SGMD), a client of CNW investing in products and brands with disruptive potential. To view the full publication, titled “Flow of Finance Funds Acquisitions and Investment Across the Cannabis Sector,” visit: http://ccw.fm/M5vyc. Also today, NetworkNewsWire released a report on the company detailing how SGMD is anticipating a surge in top line revenue growth following the acquisition of two hydroponic cultivation companies. To view the full article, visit: http://nnw.fm/P4DyU.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1225, up 3.73%, on 1,560,982 volume with 141 trades. The average volume for the last 3 months is 2,330,750 and the stock's 52-week low/high is $0.031/$0.43.

Recent News

chart

American Premium Water Corp. (HIPH)

The QualityStocks Daily Newsletter would like to spotlight American Premium Water Corp. (HIPH).

American Premium Water (OTC: HIPH) is a diversified holding company, manufacturer, distributor and marketer of branded consumer products based in Playa Vista, California. To view the full article, visit: http://nnw.fm/s4D68. Also today, the company was highlighted in an update from Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on CBD and THC beverage deals brewing as the legal cannabis market in Canada just opened up new opportunities.

American Premium Water Corp. (HIPH), headquartered in Playa Vista, California, is a diversified holding company, manufacturer, distributor and marketer of branded consumer products. HIPH, the acronym for “Hi-Power of Hydro,” maintains a portfolio of subsidiaries catering to the health-conscious consumer and luxury fashion brand connoisseur. The company’s two main pillars focus on the development of health and beauty biotech, dedicated to unlocking the power of hydrogen and nanotechnologies. Paired with cannabidiol or “CBD” in a unique beverage, the technology is proving to be a significant health and wellness option for astute consumers.

Among the company’s holdings are:

  • LALPINA Hydro beverages mix hydrogen with nanotechnology into consumer beverages that combine the best of health, nutrition and fitness to deliver short and long-term therapeutic health benefits. LALPINA Hydro utilizes atomic molecular hydrogen, or diatomic hydrogen, which converts antioxidants in the body to H2O to further enhance hydration, which helps increase endurance, reduce lactic acid and melt away fatigue. Over 500 peer-reviewed articles demonstrate hydrogen to have therapeutic potential in essentially every organ of the human body and in 150 different human disease models.
  • LALPINA Hydro CBD is a technically superior CBD-infused beverage. Using hydro and nanotechnology, LALPINA Hydro CBD encapsulates water molecules with cannabidiol molecules, making them infinitely more bioavailable and accelerating delivery to the body’s cells and tissues. Each bottle of LALPINA Hydro CBD contains 3 million nanograms of CBD free from the psychoactive compound THC (tetrahydrocannabinol). HIPH is the first to introduce a hydro-nano CBD-infused beverage on the market, which is a more effective delivery mechanism for administering CBD into the blood stream than traditional beverages or oils, with up to a 90 percent higher absorption rates.

The company recently signed a distribution agreement for its subsidiary, LALPINA Hydro CBD, to sell its beverages to two SinglePoint, Inc. (OTCQB: SING) e-commerce channels: SingleSeed.com and DIGSHydro.com. SING is a technology and investment company with a portfolio that includes mobile payments, blockchain solutions and ancillary cannabis services. HIPH will drop ship its product to the customers.

HIPH CEO Ryan Fishoff said the e-commerce arrangements “could bring in excess of a million of revenue over the life of the agreement.” The agreement serves as a pillar of the company’s e-commerce distribution strategy, driving awareness and impressions for the LALPINA brand.

In addition, HIPH seeks to market emerging fashion brands and leverage its relationship with classic retail partners while incorporating disruptive blockchain technologies to expand its retail footprint with the following:

  • Gents, a producer of luxury hats and other fine accessories and apparel, was acquired in September 2017. Gents is distributed across many luxury retail outlets including Saks Fifth Avenue, Bloomingdales, Nordstrom, and other high-end channels. The company added the Worthy streetwear brand to its portfolio in June 2018.
  • HIPH also acquired the license to operate the FashionCoinX exchange, a blockchain exchange focused on creating utility tokens for the fashion industry, and created THRD Coin, a multi-branded utility rewards token that is also the first token to be traded on the exchange. The company is leveraging its retail footprint and expertise in the fashion and apparel space with the burgeoning blockchain sector.

American Premium Water Corp. (HIPH), closed the day's trading session at $0.0685, up 0.29%, on 13,647,102 volume with 617 trades. The average volume for the last 3 months is 16,399,807 and the stock's 52-week low/high is $0.0035/$0.132.

Recent News

chart

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC: REFG) is a first-tier merchant processing cannabis industry innovator. The company serves the legal cannabis industry with a premier end-to-end payment processing solution that is FinCEN (Financial Crimes Enforcement Network) compliant. Its proprietary payment system goes by the name ‘Green’. Medical Cannabis Payment Solutions is headquartered in Cheyenne, Wyoming.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.0215, off by 2.27%, on 208,835 volume with 19 trades. The average volume for the last 3 months is 449,641 and the stock's 52-week low/high is $0.017/$0.092.

Recent News

chart

Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Next-generation energy and technology company Zenergy Brands (OTC: ZNGY) enables customers to upgrade their energy devices to more efficient, cost-reducing appliances, at no added expense. To view the full article, visit: http://nnw.fm/fNm90.

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0004, even for the day, on 12,695,600 volume with 7 trades. The average volume for the last 3 months is 19,415,096 and the stock's 52-week low/high is $0.0003/$0.03.

Recent News

chart

GreenBox POS, LLC (GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

Fresh off deployment of its latest blockchain-based hardware and software to payments solutions clients, GreenBox POS, LLC (OTC: GRBX) is focused on ramping up transaction volume. GreenBox plans to ship enough of its newest TrustGateway units pre-installed with the company’s software by year-end to generate transaction volume that’s projected to contribute $750,000 per month to net income.

GreenBox POS, LLC (GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.398, off by 0.75%, on 21,892 volume with 18 trades. The average volume for the last 3 months is 41,360 and the stock's 52-week low/high is $0.017/$1.95.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (OTC: NUGS) today announced its plans to expand its business portfolio to include cannabis cultivation. The Company has started its pre-acquisition due diligence process for prospective cultivation properties located in states where cannabis cultivation is legal. Also today, the company was highlighted in Venture Breakfast Bits, by 24/7 Market News. Additionally, the company was mentioned today in an article examining how the Bureau of Cannabis Control, together with the Department of Public Health and the Department of Food and Agriculture in California have released an updated draft set of rules that will form the permanent regulations which will govern the cannabis industry in the state.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $3.12, up 1.13%, on 13,144 volume with 53 trades. The average volume for the last 3 months is 106,278 and the stock's 52-week low/high is $0.03/$7.13.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

NetworkNewsAudio announces the Audio Press Release (APR) titled “Payment and Delivery Technologies Transform the Future of Shopping,” featuring SinglePoint, Inc. (OTCQB: SING). To hear the NetworkNewsAudio version, visit: http://nnw.fm/50orJ. To read the full editorial, visit: http://nnw.fm/aI8bJ. Additionally, the company was featured on this week’s episode of MoneyTV with Donald Baillargeon. The television program is available for immediate online viewing at: www.MoneyTV.net. To view the full press release, visit: http://nnw.fm/6kMVj.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0269, off by 1.90%, on 2,632,188 volume with 151 trades. The average volume for the last 3 months is 4,532,176 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corp. (TSX.V: FLWR), a Canadian Licensed Producer of premium cannabis products, has appointed the company’s CEO, Vinay Tolia, to its Board of Directors. To view the full press release, visit: http://nnw.fm/GC9Zx.

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.56, off by 3.78%, on 51,275 volume with 85 trades. The average volume for the last 3 months is 175,785 and the stock's 52-week low/high is $3.11/$8.00.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) was featured today in a new independent research report from Fundamental Markets. http://Fundamental-Markets.com/register/?so=NETE

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $4.85, off by 3.96%, on 202,483 volume with 752 trades. The average volume for the last 3 months is 253,810 and the stock's 52-week low/high is $3.47/$33.51.

Recent News

chart

Marifil Mines Ltd. (TSX.V: MFM) (OTC: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

Mining exploration company Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) has announced closings of multiple private placement financings, as well as the engagement of firms to provide marketing and investor relations services to the company. The Vancouver-based company is focused on exploration for cobalt, lithium and gold, as well as other metals, on its mining property holdings in Argentina.

Marifil Mines Ltd. (TSX.V: MFM) (OTC: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.105, up 2.94%, on 66,700 volume with 8 trades. The average volume for the last 3 months is 27,636 and the stock's 52-week low/high is $0.009/$0.165.

Recent News

chart

NUGL Inc. (NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL (OTC: NUGL) is a leader in the evolution of business relations, development and organic data in the cannabis industry. NUGL consistently adds new features to its internet-based search engine application that enables cannabis users to locate a specific product through a responsive directory. To view the full article, visit: http://nnw.fm/9XzHu.

NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.8399, off by 7.08%, on 148,715 volume with 211 trades. The average volume for the last 3 months is 197,055 and the stock's 52-week low/high is $0.405/$2.64.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.